Reporting on Adverse Clinical Events, 2018

DOI: 10.1177/0069477018819775

Keywords: Abiraterone (339),Dabigatran (338),Dapsone (344),Gentamicin (337),Hydralazine (345),Ibuprofen (336),Levofloxacin (341),Loperamide (342),Metformin (343),Paraphenylenediamine (334),Risperidone (333,335),Sorafenib (347),Tramadol (346),Ustekinumab (340)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text